(Received for publication August 16, 1995) The structure of the antitumor antibiotic himastatin wasdetermined using a combinationof spectroscopic and chemical degradation techniques. Himastatin is a unique dimeric cyclohexadepsipeptide joined through a biphenyl linkage between two oxidized tryptophan units. The gross structure of the dimer was established through degradative ozonolysis. Himastatin consists of dvaline, D-threonine, L-leucine, L-a-hydroxyisovaleric acid, (3i?,5i?)-5-hydroxypiperazic acid, and (2jR,3aJR,8ai^)-3a-hydroxyhexahydropyrrolo [2,3Z? ]indole 2-carboxylic acid subunits.
Himastatin (1) is a novel depsipeptide antitumor antibiotic, produced in cultured broth of Streptomyces hygroscopicus (ATCC53653). Details of the taxonomy of the producing strain, production, biological properties, isolation and physico-chemical properties of this substance have been previously reported1?2). In this paper we present details of the structure elucidation of himastatin using a combination of NMRtechniques, mass spectrometry, and chemical degradation methods.
Results
Structural Elucidation Himastatin (1) was isolated as a colorless microcrystalline solid from Streptomyces hygroscopicus strain ATCC 53653 as previously described1>2). The molecular formula of himastatin was determined to be C72H104N14O20by and L-a-hydroxyisovaleric acid. The 13C NMRspectrum revealed the presence of 36 carbon signals, which were attributed to seven methyl carbons, four methylene carbons, 12 methine carbons, three aromatic methine carbons, one quaternary oxycarbon, three aromatic quaternary carbons, and six carbonyls (amide, ester) from the gated coupled spectrum. Since the molecular formula indicated exactly twice this number of carbon atoms, it was concluded that himastatin is a symmetrical dimer.
The structural arguments presented focus initially on the (Table 1) . Fragment I (Valine): Strong splittings (/= 6.8 Hz) were observed between the two y methyl groups at 3 0.83, 0.96 and the /? methine proton at 5 2.52, diagnostic of an OH, 2, 8a OH, 2, 3, 4, 8a OH, 2, 7 6 4, 6, 7 4 NH, OH, 4, 6 6 4, 6, S 4, 7, 8a NH, OH, 3, Thra OH, 2, 3B; ThrNH, a 2, 3a
Proton correlations within the same amino acid listed unless specified otherwise. MAR. 1996 indicating a cis relationship between the C-5 hydroxyl and C-3 carboxylic acid groups. The *H NMRspectrum was again nearly identical with that reported for Based on the evidence presented, we have concluded that the 5-hydroxypiperazic unit in himastatin has the 3R, 5R
configuration. Fragment VI (3a-hydroxypyrroloindole derivative ("photo-Trp")):
The hexahydropyrroloindole structure shown in Fig. 1 2.16 (1H, dd, J=14.3, 8.0Hz, were evident from the COSYspectrum (Fig. 1 ). Other elements of fragment VI included a quaternary carbon (3 90.6) , an OH group (3 5.89 ), a tertiary nitrogen ( 3 148) and a carbonyl group (3 172.8) . Two additional sites of unsaturation (e.g. 2 rings) were necessary to satisfy the empirical formula. Additionally, the quaternary carbon (3 90.6) bearing the hydroxyl group showed long range 13C-1H coupling with the aromatic proton (57.52), two methines (3 5.ll, 5.16 ) and the geminal pair (3 2.16, 2.70) . The methine at (<5 5. 1 1) showed long range coupling to the aromatic carbon at 3 146.4, the carbon (3 60.6) bearing the 3 5. 16 proton, and the carbon (3 39.3) This ring system has been found in some fungal metabolites such as the sporidesmines and brevianamide E6). In addition, the recently reported antitumor cyclic heptapeptides, phakellistatin-3 and isophakellistatin-3 obtained from a marine sponge, also contain this moiety which was abbreviated by . The relative configuration of the photo-Trp unit in himastatin was deduced from a ROESY NMRexperiment (Table 1) . In this manner, correlations between between H-2 (3 5.16) and H-8a (3 5.ll) , and H-8a and C-3a-OH (5 5.89) indicate that the three protons are on the same face of the hexahydropyrroloindole ring system. The sequence ofamino acids in himastatin was deduced from a combination of 2D NMRmethods (Table 1) (4) as shown (Fig. 3) . Substructure analysis by MS/MStechniques revealed features consistent with the proposed structure, as shown in the fragmentation scheme (Fig. 3) . Initial loss of two H2Omolecules from the valinol moieties results in the m/z 573 substructure Since the aromatic lithium borohydride reduction product (4) is a symmetrical dimer, and the phenyl ring is trisubstituted, we reasoned that the two monomeric units ofhimastatin arejoined together through a biphenyl linkage. The biphenyl hypothesis is supported by consideration of the UVdata (Table 4)9). The relatively large extinction coefficients (s) for the lithium borohydride product (4) and himastatin (1) suggest that both incorporate a coplanar biphenyl system. Biphenyls unsubstituted at the ortho position have a greater tendancy towards coplanarity and thus have relatively large UVextinction coefficients10).
On the other hand, as illustrated in Table 4 , biphenyls which have ortho substituents have markedly reduced extinction coefficients since their sterically favored conformations are not coplanar. The UV spectra ofhimastatin (1) and its LiBH4 reduction product (4) also resemble that of benzidine (biphenyl, 4,4'-diamino) . This supports the presence of a benzidine chromophore in himastatin.
In addition, himastatin appears to be highly susceptable to oxidation. For example, when exposed to short wavelength UVlight after development on a silica gel TLCplate, the normally colorless compound(e.g. spot) briefly turns deep yellow proposed the stereochemical assignments for the photoTrp unit in himastatin to be 2(R), 3a(7?), and 8a(i?).
With the structural fragments and their sequence in himastatin now established, it was necessary to consider the gross structure of this unusual dimeric cyclodepsipeptide. In our earlier communication2^we proposed two possible structures for this symmetrical dimer: "dumbbell" structure (1) and "globular" structure (8), since at that time we were unable to distinguish between the two by spectroscopic or chemical means. The UV(s) data and ease of oxidation of the benzidine chromophorein himastatin seemed to favor structure (1) over structure (8), since the two macrocyclic rings bridging the chromophore in 8 would introduce conformational constraints and thus could prevent coplanarity of the biphenyl system. The question was finally settled by degradation through ozonolysis (Fig. 4) . Treatment of a chilled (-78°C) solution of himastatin with an ozone stream resulted in rapid loss of starting material.
Following reductive workup, initial pro filing of the crude product by LC/MS analysis revealed numerous components. The majority of these were in the 600~800 MW range, with a major component having MW757, nearly half the mass of starting material. This result clearly favors structure (1) for the dimer, since under similar conditions one would expect analogous products derived from structure (8) to be in the 1200-1600 MWrange.
The major, UVabsorbing component (10) (Fig. 4) , thus confirming the "dumbbell" structure (1) confirming the cyclic sequence of amino acid fragments in himastatin (Fig. 4) .
Discussion
The structure of himastatin (1) a-hydroxyisovaleric acid were established by chiral GC methods. The stereochemistry of the 5-hydroxypiperazic acid unit was deduced from NMRand optical data for two 2,4-dinitrophenyl derivatives. The gross structure (1) was finally established through degradative ozonolysis of the dimer. Himastatin showed antimicrobial activity against gram-positive bacteria, and had in vitro cytotoxicity in tumor cell lines (HCT-1 16 IC50 9.7 jug/ml; B16-F10 IC50 9.7 jug/ml; Moser Human Colon Cells IC50 15.6 /ig/ml). It also had modest in vivo activity in murine tumor models (IP dosing/IP implant): P388 T/C 140 at 0.8mg/kg/dose; B16 melanoma T/C 136 at 1.2mg/kg/ dose1}. The compound, however, was inactive in IV models. Studies by Mamberet al. suggest that micelle formation and the interaction between himastatin and cell membrane lipids may explain the lack of distal site activity against murine tumors in vivo1 5). The importance of the photo-Trp unit and/or benzidine chromophore in himastatin to the antitumor activity is unknown. Further studies with himastatin analogs will be necessary to address these issues. MeOH-J4 Su 3.34, 3C 49.8). 15N shifts are relative to external anhydrous liquid ammonia (<5N 0.0). Spectra were recorded at ambient temperature. UVabsorption spectra were determined using a Hewlett Packard 8452A diode array spectrophotometer. IR spectra were obtained on KBrdiscs using a Perkin Elmer 1800 fourier transform spectrometer. CDspectra were recorded with a Jasco J-720 spectropolarimeter. Specific rotations were recorded with a Perkin-Elmer 241 polarimeter. Low resolution mass spectrometric analyses were performed with a Finnigan MATTSQ70 tandem quadrupole mass spectrometer in the positive ion FABmode, using a m-nitrobenzyl alcohol matrix and argon as the primary particle source. DCIMSmeasurementswere performed with a Finnigan 4500 quadrupole instrument. Electrospray MSanalyses were conducted with a Finnigan TSQ7000 triple sector quadrupole instrument, using 0.1% sodium hydroxide in acetonitrile -water 1 : 1 as the mobile phase. Accurate mass measurements were obtained by peak matching either on a V.G. Instruments, 70SE double focusing mass spectrometer with either substance P or nitrobenzyl alcohol as a reference, or the Kratos MS50with a cesium iodide saturated glycerol solution as the reference. MS/MSsubstructure analyses were performed with a Finnigan MAT TSQ70 instrument, using argon for collisionally activated dissociation (CAD) with an indicated collision gas pressure of 1.0 mTorr and collision energies of40~60 eV. Full scan mass spectra were acquired with a 1 second scan rate while MS/MSspectra were acquired with a 1~4 second scan rate. LC/MSanalyses were obtained using a Sciex API III mass spectrometer equipped with a Perkin Elmer Series 410 HPLC pump and a Perkin Elmer LC 90 UV spectrophotometer; Chromatographic conditions used: Zorbax C-18, 4.6mmx25cm HPLC column, mobile phase acetonitrile -ammonium acetate bufferpH 5.0, 2mM, gradient, 1 : 9 to 9 : 1 over30minutes, held for an additional 10 minutes, flowrate 1.0 ml/minute, UVdetection at 254nm.
Himastatin (1) 3393, 3335, 2965 , 2932 , 2876 , 1731 , 1675 , 1630sh, 1532 , 1484 , 1469 , 1454 , 1422 , 1392 , 1330 , 1308 , 1250 , 1187 , 1154 , 1101 , 1019 UV Amax (MeOH) 286nm (a 27,900); CD X nm (As) (MeOH) Prior to GCanalysis, the amino acids in the hydrolysate were converted to their respective pentafluoropropyl isopropyl esters using the Alltech PFP-IPA Amino Acid Derivatization Kit (Cat No. 18093), as described in the product bulletin. In this manner, the major components
shown to be present were D-valine, D-threonine, and L-leucine.
Chirality Determination for a-Hydroxyisovaleric Acid Himastatin (1) (100mg) was hydrolyzed in 6n HC1 by heating in a sealed tube at 100°C for 20 hours. Silica Gel TLC using isopropanol-ammonium hydroxide 3 : 1 followed by detection with iodoplatinate spray reagent revealed a bluish-white spot which matched in terms of MAR. 1996 Rf with authentic a-hydroxyisovaleric acid. Preparative TLC of the crude hydrolysate using the same conditions provided an enriched sample of a-hydroxyisovaleric acid for chiral GCanalysis. Prior to analysis, the sample was derivatized to the 2-trimethylsiloxycarboxamide and analysed using a Perkin-Elmer Sigma 2000 Capillary Chromatograph equipped with a Chiralsil-Val III 25 m x 0.25 mmfused silica capillary column; injector at 250°C, detector at 300°C17). Upon comparison with standards of dl-and D-a-hydroxyisovaleric acid using this procedure, the major enantiomer present in this sample was shown to be L-a-hydroxyisovaleric acid.
Acid (2) Himastatin (1) culture was incubated at 28°C on a Gyrotary shaker (Model G53, New Brunswick Scientific) set at 250rpm. After 5 days, 5ml aliquots were transferred to ten 500 ml Erlenmeyer flasks containing 1 00 ml of the production mediumwith the same composition as the vegetative medium. The production culture was incubated at 28°C, and 250rpm on the same shaker for7 days. 15N enriched himastatin was isolated from the above culture (1 liter) by extraction of the whole broth with an equal volume of ethyl acetate. The crude extract was chromatographed by silica gel VLC(2.5 x 10cm column). Elution was begun with (100ml each) ethyl acetate, followed by chloroform, 1%, 2%, and 3% methanol in chloroform. The chromatogram was followed by TLC (CHC13-MeOH9 : 1). The 1~2% methanol fractions were further purified by silica gel preparative TLC using CHC13-MeOH95 : 5 as the developing solvent to afford 29mg 15N-himastatin. The relevant^N-1!! NMRdata appear in Table 2 .
Permethylation of Himastatin
Himastatin (1) Using the same procedure, the 13C-permethyl derivative was prepared using 13C-labeled methyl iodide. The key 13C-1H 2D NMRlong range couplings appear in Table 3 .
Lithium Borohydride Reduction Product (4) Himastatin (1) (100 mg) was dissolved in 3 ml dry THF, and added slowly to a suspension of lithium borohydride (~10mg, 6eqs.) in 20ml THF. The contents were heated to reflux, with stirring for 30 minutes. Mild foaming was observed. The mixture was cooled and excess reagent quenched with 2ml acetone, adjusted to pH 7 with dropwise addition of 1 n HC1, and filtered. The filtrate was purified by silica gel preparative TLC using chloroform -methanol -water -ammonium hydroxide 120 : 45 : 8 : 0.5 as the developing solvent, affording 5mg reduction product 
